HC Wainwright Has Positive View of Verona Pharma Q2 Earnings
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at HC Wainwright lifted their Q2 2025 EPS estimates for Verona Pharma in a research note issued to investors on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.08) per share for the quarter, up from their previous […]
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Stock analysts at HC Wainwright lifted their Q2 2025 EPS estimates for Verona Pharma in a research note issued to investors on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.08) per share for the quarter, up from their previous […]
